Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Minority Interest (2024 - 2025)

Historic Minority Interest for Coeptis Therapeutics Holdings (COEP) over the last 2 years, with Q3 2025 value amounting to $551195.0.

  • Coeptis Therapeutics Holdings' Minority Interest rose 24955.67% to $551195.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $551195.0, marking a year-over-year increase of 24955.67%. This contributed to the annual value of $485102.0 for FY2024, which is N/A changed from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Minority Interest stood at $551195.0 for Q3 2025, which was up 24955.67% from $984300.0 recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Minority Interest peaked at $984300.0 during Q1 2025, and registered a low of $157684.0 during Q3 2024.